Related Experiment Video

Updated: Jun 1, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Novel therapies in non-small cell lung cancer

O Zaba1, C Grohe, J Merk

  • 1ELK Berlin Chest Hospital, Berlin, Germany. okau.zaba@elk-berlin.de

Minerva Chirurgica
|June 14, 2011
PubMed

Insights

New lung cancer therapies target molecular aberrations for better patient outcomes. This review highlights key biological targets and biomarkers for non-small cell lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Advances in understanding molecular aberrations driving lung cancer.
  • Need for improved systemic therapy options for non-small cell lung cancer (NSCLC) patients.

Purpose of the Study:

  • To review key biological targets and biomarkers in NSCLC treatment.
  • To present current study results on novel therapeutic strategies.

Main Methods:

  • Literature review of recent advancements in NSCLC systemic therapy.
  • Focus on specific targets: EGFR mutations, anti-angiogenesis, multi-kinase inhibition, vascular disrupting agents, vaccines, mTOR inhibitors, TRAIL inhibition.
  • Inclusion of relevant biomarkers and their clinical significance.

Main Results:

  • Identification of critical molecular targets like EGFR mutations.
  • Overview of emerging therapies including anti-angiogenesis and multi-kinase inhibitors.
  • Discussion of biomarkers aiding personalized NSCLC treatment strategies.

Conclusions:

  • Systemic cancer therapy for NSCLC is rapidly evolving based on molecular insights.
  • Targeted therapies and biomarkers offer promising avenues for improved patient outcomes.
  • Continued research is essential to translate these findings into clinical practice.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...